## Core Concept
Meglitinides are a class of oral hypoglycemic agents used in the management of type 2 diabetes mellitus. They work by stimulating insulin secretion from the pancreatic beta cells. The primary mechanism involves closing potassium channels, which leads to cell depolarization, opening of calcium channels, and subsequent insulin release.

## Why the Correct Answer is Right
Meglitinides, such as repaglinide and nateglinide, are known for their rapid onset and short duration of action, which helps in controlling postprandial glucose levels. They are often administered before meals to manage the increase in blood glucose that occurs after eating. Their mechanism of action through the closure of ATP-sensitive potassium channels in the pancreatic beta cells results in insulin secretion.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, one would assess each statement for its accuracy regarding meglitinides, such as their mechanism, usage, side effects, or pharmacokinetics.
- **Option B:** Similarly, without the content of Option B, one would evaluate its claim about meglitinides, determining if it's a true statement about their use, efficacy, or safety profile.
- **Option C:** This option's details are also missing, but the process would involve verifying the statement against known facts about meglitinides.
- **Option D:** Without specifics, the assessment would focus on whether the statement accurately reflects a characteristic of meglitinides.

## Clinical Pearl / High-Yield Fact
A key point to remember about meglitinides is that they are particularly useful for patients with type 2 diabetes who have a significant postprandial glucose surge. They are usually taken before meals and are beneficial for individuals with irregular eating schedules or those who cannot adhere to a strict regimen of taking medications at the same time every day.

## Correct Answer: D.